Virpax Pharmaceuticals In... (VRPX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.35
0.00 (0.29%)
At close: Jan 15, 2025, 3:59 PM
0.34
-2.06%
After-hours Jan 15, 2025, 07:54 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
PE Ratio | -0.25 | -0.34 | -3.31 | -7.2 | -9.93 | -122.27 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.94 | 0.44 | 1.07 | -7.66 | -12.46 | -270.74 |
P/FCF Ratio | -0.38 | -0.41 | -2.76 | -23.32 | -30.09 | -179.44 |
P/OCF Ratio | -0.38 | -0.41 | -2.76 | -23.32 | -30.09 | -179.44 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | -0.37 | -0.46 | -0.42 |
Quick Ratio | 1.25 | 6.36 | 18.96 | 0.02 | 0.02 | 0.05 |
Current Ratio | 1.25 | 6.36 | 18.96 | 0.02 | 0.02 | 0.05 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | -129.55 | -28.36 | -25.53 | -175.34 |
Return on Equity (ROE) | -7.85 | -1.29 | -0.32 | 1.06 | 1.26 | 2.21 |
Return on Assets (ROA) | -1.58 | -1.09 | -0.31 | -9.64 | -73.44 | -42.94 |
Return on Capital (ROIC) | -8.11 | -1.32 | -0.32 | 1.31 | 1.16 | 2.20 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |